CVE-2026-34268
âšī¸ lowSummary
Vulnerability in the Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition product of Oracle Java SE (component: Security). Supported versions that are affected are Oracle Java SE: 8u481, 8u481-b50, 8u481-perf, 11.0.30, 17.0.18, 21.0.10, 25.0.2, 26; Oracle GraalVM for JDK: 17.0.18 and 21.0.10; Oracle GraalVM Enterprise Edition: 21.3.17. Difficult to exploit vulnerability allows unauthenticated attacker with logon to the infrastructure where Oracle Java SE, Oracle GraalVM fo
Description
Vulnerability in the Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition product of Oracle Java SE (component: Security). Supported versions that are affected are Oracle Java SE: 8u481, 8u481-b50, 8u481-perf, 11.0.30, 17.0.18, 21.0.10, 25.0.2, 26; Oracle GraalVM for JDK: 17.0.18 and 21.0.10; Oracle GraalVM Enterprise Edition: 21.3.17. Difficult to exploit vulnerability allows unauthenticated attacker with logon to the infrastructure where Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition executes to compromise Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition accessible data. Note: This vulnerability can be exploited by using APIs in the specified Component, e.g., through a web service which supplies data to the APIs. This vulnerability also applies to Java deployments, typically in clients running sandboxed Java Web Start applications or sandboxed Java applets, that load and run untrusted code (e.g., code that comes from the internet) and rely on the Java sandbox for security. CVSS 3.1 Base Score 2.9 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:H/PR:N/UI:N/S:U/C:L/I:N/A:N).
đ Relative Risk Intelligence
This CVE is Lower Risk - more severe than 1.8% of all 329,456 vulnerabilities in our database.
đ¯ CISA SSVC Assessment Updated: Apr 22, 2026
CVSS:3.1/AV:L/AC:H/PR:N/UI:N/S:U/C:L/I:N/A:N